2089 - Relative patient preferences for starting daily, on-demand, and long-acting injectable HIV pre-exposure prophylaxis among US men who have sex with men, 2021-2022

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

SB

S. Wilson Beckham, PhD, MPH, MA

Assistant Research Scientist
Johns Hopkins Bloomberg School of Public Health
Baltimore, Maryland, United States
MH

Marissa J. Hannah, MPH

Sr. Public Health Data Analyst
Emory University
Decatur, Georgia, United States
OE

O. Winslow Edwards, MPH

Public Health Program Associate
Emory University
Atlanta, Georgia, United States
Keith Rawlings, MD

Senior Medical Director
ViiV Healthcare
Durham, North Carolina, United States
AR

Alex R. Rinehart, PhD

Medicine Development Leader, Prevention
ViiV Healthcare
Durham, North Carolina, United States
SS

Supriya Sarkar, PhD, MPH

Director, Epidemiology and Real World Evidence
ViiV Healthcare
Baltimore, Maryland, United States
PS

Patrick S. Sullivan, DVM, PhD

Professor
Emory University
Atlanta, Georgia, United States
Vani Vannappagari, MBBS, MPH, PhD

Global Head, Epidemiology & Real World Evidence
ViiV Healthcare
Research Triangle Park, North Carolina, United States